FMC is delighted to announce the formal CRD approval of KOBAN®, a selective herbicide containing 600g/L of the active ingredient pethoxamid as an emulsifiable concentrate (EC) formulation.
Pethoxamid becomes FMCs third new herbicide active ingredient introduced to the GB market, following the launch of Fundatis® herbicide, powered by Isoflex® active in 2025 which contains the two new actives (bixlozone and beflubutamid).
Primarily used as a partner in residual herbicide mixtures, pethoxamid belongs to the long-established HRAC Group 15. This group also includes familiar active ingredients such as flufenacet and metazachlor, which are widely used across arable cropping systems.
Pethoxamid demonstrates activity across a range of both grass & broadleaved weeds species with reliable residual activity and will stand as a key active and mode of action (MOA) for future resistance management strategies.
The initial approval of pethoxamid through Koban® is focused on oilseed rape, however, the active ingredient's broad crop safety profile opens the door to wider use in the future. FMC is actively exploring opportunities to extend its application into other crops, including cereals, where it has shown particularly exciting performance alongside Fundatis® herbicide.
UK and IE Marketing Lead Geoffrey Bastard says “This approval demonstrates the depth and opportunities in FMC’s product pipeline across multiple crop sectors and highlights our commitment to providing innovative solutions to farmers to tackle key weed challenges on-farm.”
